报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
---|---|---|---|---|---|---|---|---|
2024-09-30 | 1.48% | 279.49% | 825% | 92/129 | 4.79% | 迈瑞医疗 | 28.68% | 行业排名> |
2024-06-30 | 0.16% | 118.39% | 14.29% | 95/129 | 3.05% | 迈瑞医疗 | 20.2% | 行业排名> |
2024-03-31 | 0.14% | 117.5% | 27.27% | 103/129 | 1.68% | 迈瑞医疗 | 9.12% | 行业排名> |
2023-12-31 | 0.11% | 104.58% | -71.79% | 100/129 | 5.06% | 迈瑞医疗 | 33.21% | 行业排名> |
2023-09-30 | 0.39% | 195.12% | 144.83% | 107/129 | 5.79% | 迈瑞医疗 | 28.34% | 行业排名> |
2023-06-30 | -0.87% | 19.44% | -8.75% | 113/129 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
2023-03-31 | -0.8% | 3.61% | 66.67% | 114/129 | 2.29% | 安杰思 | 8.56% | 行业排名> |
2022-12-31 | -2.4% | -126.23% | -485.37% | 114/129 | 13.44% | 九安医疗 | 146.56% | 行业排名> |
2022-09-30 | -0.41% | -105.06% | 62.04% | 108/129 | 12.77% | 九安医疗 | 140.94% | 行业排名> |
2022-06-30 | -1.08% | -120.22% | -30.12% | 115/129 | 9.3% | 九安医疗 | 142.25% | 行业排名> |
2022-03-31 | -0.83% | -125.08% | -109.07% | 104/129 | 6.26% | 九安医疗 | 142.71% | 行业排名> |
2021-12-31 | 9.15% | -54.81% | 12.82% | 88/129 | 17.49% | 热景生物 | 121.78% | 行业排名> |
2021-09-30 | 8.11% | -36.59% | 51.87% | 72/129 | 15.94% | 热景生物 | 99.69% | 行业排名> |
2021-06-30 | 5.34% | -9.18% | 61.33% | 77/129 | 11.54% | 热景生物 | 99.09% | 行业排名> |
2021-03-31 | 3.31% | 2% | -83.65% | 49/129 | 6.23% | 热景生物 | 57.63% | 行业排名> |
2020-12-31 | 20.25% | 55.29% | 58.33% | 49/129 | 25.82% | 中红医疗 | 168% | 行业排名> |
2020-09-30 | 12.79% | 2% | 117.52% | 47/129 | 19.85% | 圣湘生物 | 112.46% | 行业排名> |
2020-06-30 | 5.88% | 2% | -54.91% | 65/129 | 15.16% | 博拓生物 | 108.13% | 行业排名> |
2019-12-31 | 13.04% | -38.66% | -38.66% | 63/129 | 14.38% | 圣湘生物 | 29.33% | 行业排名> |
2018-12-31 | 21.26% | -34.14% | -34.14% | 27/129 | 12.98% | 健尔康 | 84.09% | 行业排名> |
2017-12-31 | 32.28% | 2% | 2% | 10/129 | 13.82% | 祥生医疗 | 28.56% | 行业排名> |